Results 1 to 10 of about 12,168 (228)

When BAT Precedes BIG-IV in Infant Botulism: The Need for Structured Antitoxin Decision-Pathway Reporting in Case Reports. [PDF]

open access: yesClin Case Rep
ABSTRACT In infant botulism, use of equine‐derived botulinum antitoxin before BIG‐IV may be clinically justified when the infant‐specific product is delayed. Future case reports should document the treatment decision pathway, antitoxin timing, risk–benefit justification, guardian counseling, adverse‐event monitoring, and relapse‐prevention rationale to
Awan MA, Raza HU.
europepmc   +2 more sources

Clinical-epidemiological features and improvement of botulism laboratory diagnos-102 tics in Irkutsk region

open access: yesActa Biomedica Scientifica, 2013
Irkutsk Region is one of the Russian Regions where botulism cases are registered yearly. Botulism morbidity in Irkutsk Region is analysed for the ten-year period (since 2002); its clinical-epidemiological features are revealed at the present stage ...
O. A. Noskova   +6 more
doaj  

Isolation and Characterization of Botulinum Neurotoxin-Producing <i>Clostridium caccae</i> from Meat and Soil - China, 1990-2025. [PDF]

open access: yesChina CDC Wkly
Li W   +11 more
europepmc   +1 more source

BOTULISM

open access: yesAmerican Journal of Public Health, 1923
openaire   +3 more sources

Botulism

open access: yesCanadian Medical Association Journal
Fraser, Brooke   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy